Company / Working Capital
ADC Therapeutics SA Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$236.2M
FY2025
5-year range
$226.9M / $268.6M
FY2023-FY2025
Trend
+4.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $269M to $236M over the past 2 years.
Based on SEC 10-K filings.
$236M in FY2025.
Declined from $269M to $236M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 4.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $236.2M | +4.1% |
| FY2024 | $226.9M | -15.5% |
| FY2023 | $268.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026